In the last two years, telehealth has gone all in on GLP-1s
In Stock Retatrutide 50MG is a 50-milligram format of retatrutide, a synthetic peptide investigated as a multi receptor agonist
A Phase II trial of UBT251 in overweight and obese individuals is ongoing in China, while additional trials have been cleared in both the United States and China for type 2 diabetes, obesity, and chronic kidney disease
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as one of the most effective medications for weight management available today
06 November, 2025 | Abdul Jabbar - MPharm Retatrutide is a new experimental medication being researched as a potential weight loss treatment
Engelman reassures that GLP-1-related hair loss is typically temporary and with the right plan, its possible to help prevent and reduce shedding as your body adjusts